沢井製薬株式会社
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 日本マスタートラスト信託銀行株式会社 | 2,780,000 | 6.35% | ¥16.1B | ¥361M |
| 2 | 日本トラスティ・サービス信託銀行株式会社 | 2,461,000 | 5.62% | ¥14.2B | ¥320M |
| 4 | サワケン株式会社 | 994,000 | 2.27% | ¥5.8B | ¥129M |
| 5 | Mitsuo Sawai | 948,000 | 2.17% | ¥5.5B | ¥123M |
| 6 | Kenzo Sawai
Asset-management company of Mitsuo Sawai |
854,000 | 1.95% | ¥4.9B | ¥111M |
| 8 | BNP PARIBAS SECURITIES SERVICES LUXEMBOURG/ JASDEC SECURITIES /UCITS ASSETS | 694,000 | 1.58% | ¥4.0B | ¥90.2M |
| 9 | THE BANK OF NEW YORK MELLON 140042 | 689,000 | 1.57% | ¥4.0B | ¥89.6M |
| 10 | JP MORGAN CHASE BANK 385151 | 688,000 | 1.57% | ¥4.0B | ¥89.4M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Mitsuo Sawai | Chairman & Representative Director | 948,000 | ¥5.5B | — |
| Kenzo Sawai | President & Representative Director | 854,000 | ¥4.9B | — |
| 末吉 一彦 | Director | 2,000 | ¥11.6M | — |
| 寺島 徹 | Director | 1,000 | ¥5.8M | — |
| 小原 正敏 | Director | — | — | — |
| 東堂 なをみ | Director | 1,000 | ¥5.8M | — |
| 坪倉 忠男 | Full-time Audit & Supervisory Board Member | 1,000 | ¥5.8M | — |
| 友廣 隆宣 | Audit & Supervisory Board Member | — | — | — |
| 平野 潤一 | Audit & Supervisory Board Member | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2020 | ¥5,788 | ¥393.71 | 14.7x | ¥130.0 | 44,082,000 |